医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

First-line gefitinib in patients aged 75 or older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations: NEJ 003 study

广告
第一作者: Maemondo,M.
作者: Maemondo,M. [1] ; Minegishi,Y. [2] ; Inoue,A. [3] ; Kobayashi,K. [4] ; Harada,M. [5] ; Okinaga,S. [6] ; Morikawa,N. [7] ; Oizumi,S. [8] ; Tanaka,T. [9] ; Isobe,H. [10] ; Kudoh,S. [11] ; Hagiwara,K. ; Nukiwa,T. ; Gemmah,A.
作者单位: Department of Respiratory Medicine, Miyagi Cancer Center, Miyagi, Japan, Department of Respiratory [1] Department of Respiratory Medicine, Saitama Medical University International Medical Center [2] Department of Medicine, Hokkaido University School of Medicine, Sapporo, Japan [3] Department of Respiratory Medicine, Fukujuji Hospital, Tokyo, Japan [4] Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, Sapporo [5] Department of Geriatrics and Gerontology, Tohoku University Hospital, Sendai, Japan [6] Department of Respiratory Medicine, Tohoku Employees' Pension Welfare Hospital, Miyagi, Japan [7] Department of Internal Medicine, Infectious Disease and Oncology, Nippon Medical School, 1-1-5 [8] Department of Respiratory Medicine, Saitama Medical University, Saitama, Japan [9] Department of Medical Oncology, KKR Sapporo Medical Center, Sapporo, Japan [10] Department of Respiratory Medicine, Tohoku University Hospital, Sendai, Japan [11]
发布时间 2013-11-20
提交
  • 浏览1
Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷